SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
32 hedge funds and large institutions have $2.58M invested in Seelos Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
81% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 43
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
32
Holding in Top 10
–
Calls
$538K
Puts
$21K
Top Buyers
| 1 | +$381K | |
| 2 | +$368K | |
| 3 | +$223K | |
| 4 |
Morgan Stanley
New York
|
+$172K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$155K |
Top Sellers
| 1 | -$2.17M | |
| 2 | -$157K | |
| 3 | -$133K | |
| 4 |
Millennium Management
New York
|
-$55.8K |
| 5 |
SWA
Stratos Wealth Advisors
Beachwood,
Ohio
|
-$53K |